Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelioma, Malignant × Calcium Dobesilate × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 71 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Burkitt Lymphoma 14 Recurrence 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Neoplasms, Plasma Cell 5 Neoplasms 4 Lymphoma 4 Breast Neoplasms 4 Smoldering Multiple Myeloma 3 Neoplasm Metastasis 3 Leukemia, Biphenotypic, Acute 3 Leukemia 3 Immunoglobulin Light-chain Amyloidosis 3 Prostatic Neoplasms 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Acute 2 Fatigue 2 Carcinoma, Non-Small-Cell Lung 2 Blast Crisis 2 Waldenstrom Macroglobulinemia 1 Vomiting 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Renal Insufficiency 1

Interventions

Cisplatin 15 Pemetrexed 12 pembrolizumab 8 Nivolumab 8 Carboplatin 7 Ipilimumab 5 Cyclophosphamide 5 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4 Gemcitabine 3 Drug Therapy 3 tremelimumab 2 fludarabine 2 durvalumab 2 atezolizumab 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Radiation 2 Photochemotherapy 2 Methotrexate 2 Interleukin-2 2 Chemotherapy, Adjuvant 2 sargramostim 1 olaparib 1 niraparib 1 nintedanib 1 methoxyamine 1 lenvatinib 1 enzalutamide 1 decitabine and cedazuridine drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡